Found: 17
Select item for more details and to access through your institution.
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Is there a relationship between HIV tropism and historical genotypic resistance in treatment-experienced patients?
- Published in:
- Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18206
- By:
- Publication type:
- Article
Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era.
- Published in:
- Journal of the International AIDS Society, 2012, v. 15, p. n/a, doi. 10.7448/IAS.15.6.18104
- By:
- Publication type:
- Article
Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era.
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Long-term follow-up of HIV-infected patients in salvage therapy with raltegravir plus optimized background regimens: a multicentre Italian experience.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P38, doi. 10.1186/1758-2652-13-S4-P38
- By:
- Publication type:
- Article
Darunavir in experienced patients.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P27, doi. 10.1186/1758-2652-13-S4-P27
- By:
- Publication type:
- Article
Long-term follow-up of HIV-infected patients in salvage therapy with raltegravir plus optimized background regimens: a multicentre Italian experience.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Darunavir in experienced patients.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis.
- Published in:
- Infection, 2012, v. 40, n. 3, p. 311, doi. 10.1007/s15010-011-0237-y
- By:
- Publication type:
- Article
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study
- Published in:
- HIV Medicine, 2019, v. 20, n. 2, p. 164, doi. 10.1111/hiv.12688
- By:
- Publication type:
- Article
Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication.
- Published in:
- HIV Medicine, 2018, v. 19, n. 7, p. 452, doi. 10.1111/hiv.12611
- By:
- Publication type:
- Article
Morning dosing for dolutegravir‐related insomnia and sleep disorders.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Rate, correlates and outcomes of repeat pregnancy in HIV-infected women.
- Published in:
- HIV Medicine, 2017, v. 18, n. 6, p. 440, doi. 10.1111/hiv.12473
- By:
- Publication type:
- Article
Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 385, doi. 10.1111/hiv.12313
- By:
- Publication type:
- Article
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 1, p. 117, doi. 10.1093/jac/dkac362
- By:
- Publication type:
- Article